Efficacy and Safety of Roflumilast in Korean Patients with COPD

PURPOSE: Roflumilast is the only oral phosphodiesterase 4 inhibitor approved to treat chronic obstructive pulmonary disease (COPD) patients [post-bronchodilator forced expiratory volume in 1 second (FEV(1)) <50% predicted] with chronic bronchitis and a history of frequent exacerbations. This stud...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Yonsei Med J
Asıl Yazarlar: Lee, Jae Seung, Hong, Yoon Ki, Park, Tae Sun, Lee, Sei Won, Oh, Yeon-Mok, Lee, Sang-Do
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Yonsei University College of Medicine 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4951470/
https://ncbi.nlm.nih.gov/pubmed/27189287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2016.57.4.928
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller